Projects per year
Fingerprint
Dive into the research topics where Cancer Institute of New Jersey (CINJ), Gynecology Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
James Aikins
- Cancer Institute of New Jersey (CINJ), Gynecology Oncology - ASSOC PROF-CLIN-DIV CHIEF
Person
Projects
- 3 Finished
-
Regulation of MDR1 Expression and Drug Resistance by CD44
Rodriguez-Rust, L. (PI)
7/1/07 → 5/31/13
Project: Research project
-
Regulation of P-glycoprotein Expression and Function by CD44 in Breast Cancer
Rodriguez-Rust, L. (PI)
1/1/06 → 12/31/06
Project: Research project
-
FUNCTIONS AND INHIBITION OF HIV POLYMERASE
Rodriguez-Rust, L. (PI)
5/1/93 → 4/30/99
Project: Research project
Research output
-
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)
Taylor, S. E., Behr, S., Cooper, K. L., Mahdi, H., Fabian, D., Gallion, H., Ueland, F., Vargo, J., Orr, B., Girda, E., Courtney-Brooks, M., Olawaiye, A. B., Randall, L. M., Richardson, D. L., Sullivan, S. A., Huang, M., Christner, S. M., Beriwal, S., Lin, Y. & Chauhan, A. & 5 others, , Dec 2025, In: Cancer chemotherapy and pharmacology. 95, 1, 4.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: Study protocol for a phase II clinical trial
Frimer, M., Katcher, A., Blustein, P., Sison, C., Girda, E., Nizam, A., Tymon-Rosario, J., Goldberg, G. L., Menzin, A., Valea, F., Scanlon, L., Whyte, J. S., Sakaris, A., Pereira, E., Villella, J., Kuo, Y. S. D., Lee, J., Siebel, M., Danziger, N. & Elvin, J. & 3 others, , Jun 5 2025, In: BMJ open. 15, 6, e087115.Research output: Contribution to journal › Article › peer-review
-
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R. S., Shahin, M. S., Cantuaria, G. H., Girda, E., Lokich, E., Kavecansky, J., Leath, C. A., Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O’Cearbhaill, R. E. & Baghdadi, T. A. & 7 others, , May 2025, In: Nature medicine. 31, 5, p. 1539-1546 8 p.Research output: Contribution to journal › Article › peer-review
17 Scopus citations